Selecting vaccine strains for H3N2 human influenza A virus

Meta Gene

Volumn 4, Issue , 2015, Pages 64-72

  Suzuki, Yoshiyuki ^a  

^a NAGOYA CITY UNIVERSITY   (Japan)

Author keywords

Antigenic distance; Hemagglutinin; Influenza virus; Thermodynamic stability; Vaccine

Indexed keywords

EPITOPE; HEMAGGLUTININ; VIRUS VACCINE;

AMINO ACID SEQUENCE; ANTIGENIC VARIATION; ANTIGENICITY; ARTICLE; DRUG MECHANISM; GENETIC ALGORITHM; GENETIC ANALYSIS; HUMORAL IMMUNITY; INFLUENZA; INFLUENZA VIRUS; MATHEMATICAL PARAMETERS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEASONAL VARIATION; VACCINATION; VIRUS STRAIN;

INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

EID: 84929317526     PISSN: 22145400     EISSN: 22145400     Source Type: Journal    
DOI: 10.1016/j.mgene.2015.03.003     Document Type: Article

References (60)

1. Ahmad S., Gromiha M.M., Fawareh H., Sarai A. ASAView: database and tool for solvent accessibility representation in proteins. BMC Bioinf. 2004, 5:51.
2. Bao Y., Bolotov P., Dernovoy D., Kiryutin B., Zaslavsky L., Tatusova T., Ostell J., Lipman D. The Influenza Virus Resource at the National Center for Biotechnology Information. J. Virol. 2008, 82:596-601.
3. Bedford T., Rambaut A., Pascual M. Canalization of the evolutionary trajectory of the human influenza virus. BMC Biol. 2012, 10:38.
4. Bloom J.D., Glassman M.J. Inferring stabilizing mutations from protein phylogenies: application to influenza hemagglutinin. PLoS Comput. Biol. 2009, 5:e1000349.
5. Bush R.M., Bender C.A., Subbarao K., Cox N.J., Fitch W.M. Predicting the evolution of human influenza A. Science 1999, 286:1921-1925.
6. Centers for Disease Control and Prevention Update: influenza activity-United States, 2003-2004 season 2004, 53:284-287.
7. Centers for Disease Control and Prevention Update: influenza activity-United States, 2009-2010 season 2010, 59:901-908.
8. Coleman M.T., Dowdle W.R., Pereira H.G., Schild G.C., Chang W.K. The Hong Kong/68 influenza A2 variant. Lancet 1968, 292:1384-1386.
9. Cortese M.M., Immergluck L.C., Held M., Jain S., Chan T., Grizas A.P., Khizer S., Barrett C., Quaye O., Mijatovic-Rustemapasic S., Gautam R., Bowen M.D., Moore J., Tate J.E., Parashar U.D., Vazquez M. Effectiveness of monovalent and pentavalent rotavirus vaccine. Pediatrics 2013, 132:e25-e33.
10. Ekiert D.C., Kashyap A.K., Steel J., Rubrum A., Bhabha G., Khayat R., Lee J.H., Dillon M.A., O'Neil R.E., Faynboym A.M., Horowitz M., Horowitz L., Ward A.B., Palese P., Webby R., Lerner R.A., Bhatt R.R., Ian A., Wilson I.A. Cross-neutralization of influenza A viruses mediated by a single antibody loop. Nature 2012, 489:526-532.
11. Fitch W.M., Leiter J.M., Li X.Q., Palese P. Positive Darwinian evolution in human influenza A viruses. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:4270-4274.
12. Francis T., Salk J., Pearson H.E., Brown P.N. Protective effect of vaccination against induced influenza A. Proc. Soc. Exp. Biol. Med. 1944, 55:104-105.
13. Grantham R. Amino acid difference formula to help explain protein evolution. Science 1974, 185:862-864.
14. Guerois R., Nielsen J.E., Serrano L. Predicting changes in the stability of proteins and protein complexes: a study of more than 1000 mutations. J. Mol. Biol. 2002, 320:369-387.
15. Gupta V., Earl D.J., Deem M.W. Quantifying influenza vaccine efficacy and antigenic distance. Vaccine 2006, 24:3881-3888.
16. Han T., Marasco W.A. Structural basis of influenza virus neutralization. Ann. N. Y. Acad. Sci. 2011, 1217:178-190.
17. He J., Deem M.W. Low-dimensional clustering detects incipient dominant influenza strain clusters. Protein Eng. Des. Sel. 2010, 23:935-946.
18. Henle W., Henle G., Stokes J. Demonstration of the efficacy of vaccination against influenza type A by experimental infection of human beings. J. Immunol. 1943, 46:163-175.
19. Hensley S.E., Das S.R., Bailey A.L., Schmidt L.M., Hickman H.D., Jayaraman A., Viswanathan K., Raman R., Sasisekharan R., Bennink J.R., Yewdell J.W. Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift. Science 2009, 326:734-736.
20. Huang J.-W., King C.-C., Yang J.-M. Co-evolution positions and rules for antigenic variants of human influenza A/H3N2 viruses. BMC Bioinf. 2009, 10:S41.
21. Ito K., Igarashi M., Miyazaki Y., Murakami T., Iida S., Kida H., Takada A. Gnarled-trunk evolutionary model of influenza A virus hemagglutinin. PLoS One 2011, 6:e25953.
22. Kobayashi Y., Suzuki Y. Compensatory evolution of net-charge in influenza A virus hemagglutinin. PLoS One 2012, 7:e40422.
23. Kobayashi Y., Suzuki Y. Evidence for N-glycan shielding of antigenic sites during evolution of human influenza A virus hemagglutinin. J. Virol. 2012, 86:3445-3451.
24. Kryazhimskiy S., Dushoff J., Bazykin G.A., Plotkin J.B. Prevalence of epistasis in the evolution of influenza A surface proteins. PLoS Genet. 2011, 7:e1001301.
25. Lee M.-S., Chen J.S.-E. Predicting antigenic variants of influenza A/H3N2 viruses. Emerg. Infect. Dis. 2004, 10:1385-1390.
26. Lee M.-S., Chen M.-C., Liao Y.-C., Hsiung C.A. Identifying potential immunodominant positions and predicting antigenic variants of influenza A/H3N2 viruses. Vaccine 2007, 25:8133-8139.
27. Lees W.D., Moss D.S., Shepherd A.J. A computational analysis of the antigenic properties of haemagglutinin in influenza A H3N2. Bioinformatics 2010, 26:1403-1408.
28. Liao Y.-C., Lee M.-S., Ko C.-Y., Hsiung C.A. Bioinformatics models for predicting antigenic variants of influenza A/H3N2 virus. Bioinformatics 2008, 24:505-512.
29. Luksza M., Lassig M. A predictive fitness model for influenza. Nature 2014, 507:57-61.
30. Mitnaul L.J., Castrucci M.R., Murti K.G., Kawaoka Y. The cytoplasmic tail of influenza A virus neuraminidase (NA) affects NA incorporation into virions, virion morphology, and virulence in mice but is not essential for virus replication. J. Virol. 1996, 70:873-879.
31. Nelson D.L., Cox M.M. Lehninger Principles of Biochemistry 2008, W. H. Freeman and Company, New York. 5th edition.
32. Nelson M.I., Holmes E.C. The evolution of epidemic influenza. Nat. Rev. Genet. 2007, 8:196-205.
33. Omori R., Sasaki A. Timing of the emergence of new successful viral strains in seasonal influenza. J. Theor. Biol. 2013, 329:32-38.
34. Osterholm M.T., Kelley M.S., Sommer A., Belongia E.A. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect. Dis. 2012, 12:36-44.
35. Rambaut A., Pybus O.G., Nelson M.I., Viboud C., Taubenberger J.K., Holmes E.C. The genomic and epidemiological dynamics of human influenza A virus. Nature 2008, 453:615-619.
36. Russell C.A., Jones T.C., Barr I.G., Cox N.J., Garten R.J., Gregory V., Gust I.D., Hampson A.W., Hay A.J., Hurt A.C., de Jong J.C., Kelso A., Klimov A.I., Kageyama T., Komadina N., Lapedes A.S., Lin Y.P., Mosterin A., Obuchi M., Odagiri T., Osterhaus A.D.M.E., Rimmelzwaan G.F., Shaw M.W., Skepner E., Stohr K., Tashiro M., Fouchier R.A.M., Smith D.J. Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine 2008, 26:D31-D34.
37. Russell C.A., Jones T.C., Barr I.G., Cox N.J., Garten R.J., Gregory V., Gust I.D., Hampson A.W., Hay A.J., Hurt A.C., de Jong J.C., Kelso A., Klimov A.I., Kageyama T., Komadina N., Lapedes A.S., Lin Y.P., Mosterin A., Obuchi M., Odagiri T., Osterhaus A.D.M.E., Rimmelzwaan G.F., Shaw M.W., Skepner E., Stohr K., Tashiro M., Fouchier R.A.M., Smith D.J. The global circulation of seasonal influenza A (H3N2) viruses. Science 2008, 320:340-346.
38. Schymkowitz J.W.H., Rousseau F., Martins I.C., Ferkinghoff-Borg J., Stricher F., Serrano L. Prediction of water and metal binding sites and their affinities by using the Fold-X force field. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:10147-10152.
39. Shih A.C.-C., Hsiao T.-C., Ho M.-S., Li W.-H. Simultaneous amino acid substitutions at antigenic sites drive influenza A hemagglutinin evolution. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:6283-6288.
40. Skehel J.J., Wiley D.C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 2000, 69:531-569.
41. Smith D.J., Lapedes A.S., de Jong J.C., Bestebroer T.M., Rimmelzwaan G.F., Osterhaus A.D.M.E., Fouchier R.A.M. Mapping the antigenic and genetic evolution of influenza virus. Science 2004, 305:371-376.
42. Soares-Weiser K., Maclehose H., Ben-Aharon I., Goldberg E., Pitan F., Cunliffe N. Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database Syst. Rev. 2010, CD008521.
43. Soundararajan V., Zheng S., Patel N., Warnock K., Raman R., Wilson I.A., Raguram S., Sasisekharan V., Sasisekharan R. Networks link antigenic and receptor-binding sites of influenza hemagglutinin: mechanistic insight into fitter strain propagation. Sci. Rep. 2011, 1:200.
44. Steinbruck L., Klingen T.R., McHardy A.C. Computational prediction of vaccine strains for human influenza A (H3N2) viruses. J. Virol. 2014, 88:12123-12132.
45. Suzuki Y. Negative selection on neutralization epitopes of poliovirus surface proteins: implications for prediction of candidate epitopes for immunization. Gene 2004, 328:127-133.
46. Suzuki Y. Natural selection on the influenza virus genome. Mol. Biol. Evol. 2006, 23:1902-1911.
47. Suzuki Y. Positive selection operates continuously on hemagglutinin during evolution H3N2 human influenza A virus. Gene 2008, 427:111-116.
48. Suzuki Y. Detection of positive selection eliminating effects of structural constraints in hemagglutinin of H3N2 human influenza A virus. Infect. Genet. Evol. 2013, 16:93-98.
49. Suzuki Y. Predictability of antigenic evolution for H3N2 human influenza A virus. Genes Genet. Syst. 2013, 88:225-232.
50. Suzuki Y., Nei M. Origin and evolution of influenza virus hemagglutinin genes. Mol. Biol. Evol. 2002, 19:501-509.
51. Tomita M., Hashimoto K., Takahashi K., Matsuzaki Y., Matsushima R., Saito K., Yugi K., Miyoshi F., Nakano H., Tanida S., Saito Y., Kawase A., Watanabe N., Shimizu T., Nakayama Y. The E-CELL project: towards integrative simulation of cellular processes. N. Gener. Comput. 2000, 18:1-12.
52. Treanor J. Weathering the influenza vaccine crisis. N. Engl. J. Med. 2004, 351:2037-2040.
53. Whittle J.R.R., Zhang R., Khurana S., King L.R., Manischewitz J., Golding H., Dormitzer P.R., Haynes B.F., Walter E.B., Moody M.A., Kepler T.B., Liao H.-X., Harrison S.C. Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:14216-14221.
54. Wiley D.C., Wilson I.A., Skehel J.J. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 1981, 289:373-378.
55. Wilson I.A., Skehel J.J., Wiley D.C. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3Å resolution. Nature 1981, 289:366-373.
56. World Health Organization Influenza (Seasonal) http://www.who.int/mediacentre/factsheets/fs211/en/index.html.
57. World Health Organization Recommended composition of influenza virus vaccines for use in the 2014-2015 northern hemisphere influenza season. Wkly. Epidemiol. Rec. 2014, 89:93-104.
58. World Health Organization Recommended composition of influenza virus vaccines for use in the 2015 southern hemisphere influenza season. Wkly. Epidemiol. Rec. 2014, 89:441-452.
59. Xia Z., Jin G., Zhu J., Zhou R. Using a mutual information-based site transition network to map the genetic evolution of influenza A/H3N2 virus. Bioinformatics 2009, 25:2309-2317.
60. Xia Z., Huynh T., Kang S.-g., Zhou R. Free-energy simulations reveal that both hydrophobic and polar interactions are important for influenza hemagglutinin antibody binding. Biophys. J. 2012, 102:1453-1461.